Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Lazydays Holdings Inc

Start price
Target price
Perf. (%)
€7.25
04.12.23
€14.00
04.12.24
-26.90%
04.01.24

Could be very worthwhile Investment >20% year
buy
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€2.34
02.12.23
€4.00
31.12.25
12.82%
07.01.24

Could be very worthwhile Investment >20% year
buy
Cemtrex Inc.

Start price
Target price
Perf. (%)
€0.26
02.12.23
€7.00
31.01.26
-
04.12.23

Could be very worthwhile Investment >20% year
buy
Nuzee Inc.

Start price
Target price
Perf. (%)
€1.67
02.12.23
€3.00
30.11.25
-
04.12.23

Could be very worthwhile Investment >20% year
Altimmune

Start price
Target price
Perf. (%)
€3.45
02.12.23
€1.00
02.12.24
114.68%
09.12.23

overvalued
negative Cash Flow expected
Very little Investments for future growth
Risky balance sheet
Altimmune

Start price
Target price
Perf. (%)
€3.45
02.12.23
€1.00
02.12.24
114.68%
09.12.23

overvalued
negative Cash Flow expected
Probably not worthwhile Investment
Revenue decline/stagnation expected
buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€19.88
01.12.23
€22.00
-
20.12.23

Undervalued
ROE higher than 15% per year
Revenue growth > 30% per year expected
Small Risks for its business
buy
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€1.04
29.11.23
€1.00
29.11.24
12.31%
07.12.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Inotiv Inc.

Start price
Target price
Perf. (%)
€2.46
28.11.23
€0.000
28.11.24
26.83%
09.12.23

Risky Investment
EBIT decline > 20% expected
Decining EBIT margin than peer group
High valuation
buy
Gevo Inc.

Start price
Target price
Perf. (%)
€1.05
27.11.23
€8.00
27.11.24
4.87%
09.12.23

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Consolidated Uranium Inc.

Start price
Target price
Perf. (%)
€1.33
27.11.23
€3.00
27.11.24
0.00%
09.12.23

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.05
26.11.23
-
26.11.24
19.56%
08.12.23

Could be worthwhile Investment >10% per year
buy
Gevo Inc.

Start price
Target price
Perf. (%)
€1.08
26.11.23
€1.00
26.11.24
1.24%
11.12.23

Probably not worthwhile Investment
negative Cash Flow expected
Low dividend yield expected
High valuation
buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€19.88
23.11.23
€25.00
23.12.23
-
24.12.23

Could be worthwhile Investment >10% per year
buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€19.88
23.11.23
€20.00
-
23.11.23

Undervalued
ROE higher than 15% per year
Revenue growth > 30% per year expected
Small Risks for its business
buy
Kawasaki Kisen Kaisha Ltd

Start price
Target price
Perf. (%)
€31.10
23.11.23
-
23.11.24
2.70%
25.11.23

buy
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€1.02
22.11.23
€1.00
22.11.24
1.96%
29.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€1.02
21.11.23
€1.00
21.11.24
0.39%
22.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
HelloFresh SE

Start price
Target price
Perf. (%)
€14.99
21.11.23
€18.00
21.11.24
-3.84%
29.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
BT Group plc ADR

Start price
Target price
Perf. (%)
€10.00
19.11.23
€2.00
01.01.25
-
23.11.23

buy
HelloFresh SE

Start price
Target price
Perf. (%)
€16.36
17.11.23
€18.00
17.11.24
-8.35%
21.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€0.96
12.11.23
-
12.11.24
8.88%
24.11.23

Could be worthwhile Investment >10% per year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.95
11.11.23
-
11.11.24
-
11.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Aytu Biopharma Inc.

Start price
Target price
Perf. (%)
€2.72
07.11.23
€5.30
07.12.23
-9.56%
13.11.23

Could be very worthwhile Investment >20% year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€0.81
05.11.23
-
05.11.24
15.43%
11.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies